Group items tagged Cancer - PharmaMics

Advaxis entering into a master clinical trial agreement GRU Cancer Center - 0 views

clinicaltrials.pharmaceutical-business-review.com/...u-cancer-center-060214-4172928

pharmacy drugs

shared by Alex Parker on 07 Feb 14 - No Cached

Alex Parker on 07 Feb 14

Advaxis, a biotechnology company developing the next generation of cancer immunotherapies, has expanded its relationship by entering into a master clinical trial agreement with GRU Cancer Center at Georgia Regents University to conduct four Phase I/II clinical trials.

<div class="cArrow"> </div><div class="cContentInner">Advaxis, a biotechnology company developing the next generation of cancer immunotherapies, has expanded its relationship by entering into a master clinical trial agreement with GRU Cancer Center at Georgia Regents University to conduct four Phase I/II clinical trials.</div>

...

Cancel

New Prostate Cancer Drug Promising in Early Trials - 2 views

It's early in the process, but researchers say early trials of a new drug for treating advanced prostate cancer are producing encouraging results. read more .. in www.pharmamics.blogspot.com

New Drugs Prostate Cancer

started by Pharma Mics on 08 Apr 09 no follow-up yet

Lung cancer blood test may replace tumour biopsy - 0 views

www.medicaldevice-network.com/...lung-cancer-blood-test

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #lungcancer #cancertreatment #bloodtest #biopsy

shared by ramchintamaneni on 21 Oct 19 - No Cached

ramchintamaneni on 21 Oct 19

Patients with advanced non-small cell lung cancer may have tumour biopsy replaced with a simple blood test to assess their treatment options.

<div class="cArrow"> </div><div class="cContentInner">Patients with advanced non-small cell lung cancer may have tumour biopsy replaced with a simple blood test to assess their treatment options.</div>

...

Cancel

TC BioPharm, Medinet to develop new cancer therapies - 1 views

drugdiscovery.pharmaceutical-business-review.com/...ancer-therapies-120314-4194672

drugs pharmacy New

shared by Alex Parker on 13 Mar 14 - No Cached

Alex Parker on 13 Mar 14

Scottish biotechnology firm TC BioPharm (TCB) and Japanese immuno-cell therapy company Medinet have entered into a strategic collaboration to develop a new treatment for different types of cancer.

<div class="cArrow"> </div><div class="cContentInner">Scottish biotechnology firm TC BioPharm (TCB) and Japanese immuno-cell therapy company Medinet have entered into a strategic collaboration to develop a new treatment for different types of cancer.</div>

...

Cancel

Evotec, Debiopharm to research and develop new cancer treatments - 1 views

contractresearch.pharmaceutical-business-review.com/...ncer-treatments-030414-4208083

drugs pharmacy

shared by Alex Parker on 04 Apr 14 - No Cached

Alex Parker on 04 Apr 14

Germany based drug discovery firm Evotec has entered into a research collaboration and licensing deal with Swiss biopharmaceutical firm Debiopharm Group to research and develop new cancer treatments

<div class="cArrow"> </div><div class="cContentInner">Germany based drug discovery firm Evotec has entered into a research collaboration and licensing deal with Swiss biopharmaceutical firm Debiopharm Group to research and develop new cancer treatments</div>

...

Cancel

ESMO 2019: ImmunoGen's ovarian cancer drug fails to meet PFS - 0 views

www.clinicaltrialsarena.com/...esmo-immunogen

#esmo2019 #esmocongress #esmoconference #ovariancancer #medicalnews #medicalindustry

shared by ramchintamaneni on 07 Oct 19 - No Cached

ramchintamaneni on 07 Oct 19

ImmunoGen has presented full data from Phase 3 Forward I study of Mirvetuximab Soravtansine in ovarian cancer at the ESMO 2019 Congress in Barcelona, Spain.

<div class="cArrow"> </div><div class="cContentInner">ImmunoGen has presented full data from Phase 3 Forward I study of Mirvetuximab Soravtansine in ovarian cancer at the ESMO 2019 Congress in Barcelona, Spain.</div>

...

Cancel

Spectrum's cancer drug Beleodaq gets FDA priority review - 0 views

drugdelivery.pharmaceutical-business-review.com/...priority-review-070214-4173700

drugs pharmacy legal

shared by Alex Parker on 10 Feb 14 - No Cached

Alex Parker on 10 Feb 14

US-based Spectrum Pharmaceuticals has announced that its new drug application (NDA) for Beleodaq has been accepted for filing by the FDA

<div class="cArrow"> </div><div class="cContentInner">US-based Spectrum Pharmaceuticals has announced that its new drug application (NDA) for Beleodaq has been accepted for filing by the FDA</div>

...

Cancel

ESMO 2019: Seven promising liquid biopsy companies at the conference - 1 views

www.medicaldevice-network.com/...o-2019-liquid-biopsy-companies

drugs pharmacy Pharmaceutical

shared by Alex Parker on 27 Sep 19 - No Cached

Alex Parker on 27 Sep 19

Research and development (R&D) in liquid biopsy is increasingly being funded by both public and private sectors due to its promising features such as early detection of cancer tumour, new lesion characterisation and identification of cancer drug target.

<div class="cArrow"> </div><div class="cContentInner">Research and development (R&D) in liquid biopsy is increasingly being funded by both public and private sectors due to its promising features such as early detection of cancer tumour, new lesion characterisation and identification of cancer drug target.</div>

...

Cancel

non-small cell lung cancer: AstraZeneca's Tagrisso trial results presented - 0 views

www.clinicaltrialsarena.com/...019-non-small-cell-lung-cancer

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #lungcancer #cancertreatment #nsclc #flaura

shared by ramchintamaneni on 22 Oct 19 - No Cached

ramchintamaneni on 22 Oct 19

Final results from the Phase III FLAURA trial investigating AstraZeneca's Tagrissofinal reinforce the therapy as the SOC for first-line treatment of patients with EGFRm advanced NSCLC.

<div class="cArrow"> </div><div class="cContentInner">Final results from the Phase III FLAURA trial investigating AstraZeneca's Tagrissofinal reinforce the therapy as the SOC for first-line treatment of patients with EGFRm advanced NSCLC.</div>

...

Cancel

Roche's Tecentriq: Phase III IMpower110 study at ESMO 2019 - 0 views

www.pharmaceutical-technology.com/...esmo-2019-roches-tecentriq

#lungcancertreatment #esmo2019 #esmocongress #esmoconference #esmocongress2019 #roche #lungcancer

shared by ramchintamaneni on 18 Oct 19 - No Cached

ramchintamaneni on 18 Oct 19

Roche's Tecentriq: Results demonstrated that first-line treatment of patients with advanced non-small cell lung cancer and high programmed cell death ligand-1 expression who used Roche's Tecentriq monotherapy resulted in improved overall survival compared with platinum-based chemotherapies.

<div class="cArrow"> </div><div class="cContentInner">Roche's Tecentriq: Results demonstrated that first-line treatment of patients with advanced non-small cell lung cancer and high programmed cell death ligand-1 expression who used Roche's Tecentriq monotherapy resulted in improved overall survival compared with platinum-based chemotherapies.</div>

...

Cancel

Agenus acquires Swiss biopharmaceutical firm 4-Antibody - 0 views

drugdiscovery.pharmaceutical-business-review.com/...firm-4-antibody-140214-4177763

drugs pharmacy

shared by Alex Parker on 14 Feb 14 - No Cached

Alex Parker on 14 Feb 14

US-based developer of new immunotherapeutics, including a portfolio of checkpoint modulators, anti-cancer vaccines and adjuvants, Agenus has completed the acquisition of Switzerland-based biopharmaceutical firm 4-Antibody.

<div class="cArrow"> </div><div class="cContentInner">US-based developer of new immunotherapeutics, including a portfolio of checkpoint modulators, anti-cancer vaccines and adjuvants, Agenus has completed the acquisition of Switzerland-based biopharmaceutical firm 4-Antibody.</div>

...

Cancel

Novartis announces acquisition of CoStim Pharmaceuticals - 0 views

processandproduction.pharmaceutical-business-review.com/...pharmaceuticals-180214-4179543

drugs pharmacy

shared by Alex Parker on 19 Feb 14 - No Cached

Alex Parker on 19 Feb 14

Novartis has acquired CoStim Pharmaceuticals, an immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.

<div class="cArrow"> </div><div class="cContentInner">Novartis has acquired CoStim Pharmaceuticals, an immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.</div>

...

Cancel

ESMO: Kisqali shows superior overall survival in breast cancer - 0 views

www.clinicaltrialsarena.com/...esmo-novartis-kisqali

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #drugdevelopment #medicalnews #medicalindustry

shared by ramchintamaneni on 07 Oct 19 - No Cached

ramchintamaneni on 07 Oct 19

Novartis has announced results from the Monaleesa-3 trial at the European Society for Medical Oncology (ESMO) Congress 2019.

<div class="cArrow"> </div><div class="cContentInner">Novartis has announced results from the Monaleesa-3 trial at the European Society for Medical Oncology (ESMO) Congress 2019.</div>

...

Cancel

Group items tagged

Advaxis entering into a master clinical trial agreement GRU Cancer Center - 0 views

New Prostate Cancer Drug Promising in Early Trials - 2 views

Lung cancer blood test may replace tumour biopsy - 0 views

TC BioPharm, Medinet to develop new cancer therapies - 1 views

Evotec, Debiopharm to research and develop new cancer treatments - 1 views

ESMO 2019: ImmunoGen's ovarian cancer drug fails to meet PFS - 0 views

Spectrum's cancer drug Beleodaq gets FDA priority review - 0 views

ESMO 2019: Seven promising liquid biopsy companies at the conference - 1 views

non-small cell lung cancer: AstraZeneca's Tagrisso trial results presented - 0 views

Roche's Tecentriq: Phase III IMpower110 study at ESMO 2019 - 0 views

Agenus acquires Swiss biopharmaceutical firm 4-Antibody - 0 views

Novartis announces acquisition of CoStim Pharmaceuticals - 0 views

ESMO: Kisqali shows superior overall survival in breast cancer - 0 views

Related searches